Rakovina Therapeutics Inc. Stock
Stocks
RKV
CA75103L3092
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Toronto S.E.
15:59:59 2026-11-02 EST
|
5-day change | 1st Jan Change | ||
| 0.1550 CAD | -16.22% |
|
-6.06% | +55.00% |
| Market Cap | 4.42M 4.95M 4.05M 3.69M 6.91M 468M 7.05M 48.4M 19.51M 247M 18.56M 18.17M 781M | P/E 2026 * |
-15.5x | P/E 2027 * | -15.5x |
|---|---|---|---|---|---|
| Enterprise Value | 4.98M 5.58M 4.57M 4.15M 7.79M 528M 7.95M 54.56M 21.99M 279M 20.92M 20.48M 880M | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
94.32% | Yield 2026 * |
-
| Yield 2027 * | - |
Toronto S.E.CAD
| Markets | Quality | ||
|---|---|---|---|
Toronto S.E.
| RKV | Delayed | |
OTC Markets
| RKVTF | Delayed | |
|
Deutsche Boerse AG
| 7JO0 | Delayed | |
|
Börse Stuttgart
| 7JO0 | Delayed | |
|
Tradegate
| 7JO0 | Real-time | |
|
Boerse Muenchen
| 7JO0 | Real-time |
| 1 day | -16.22% | ||
| 1 week | -6.06% | ||
| Current month | -16.22% | ||
| 1 month | -42.59% | ||
| 3 months | +29.17% | ||
| 6 months | +6.90% | ||
| Current year | +55.00% |
| 1 week | 0.15 |  | 0.19 |
| 1 month | 0.15 | | 0.28 |
| Current year | 0.09 | | 0.32 |
| 1 year | 0.08 | | 0.32 |
| 3 years | 0.05 | | 2.3 |
| 5 years | 0.05 | | 3 |
| 10 years | 0.05 | | 3.95 |
| Manager | Title | Age | Since |
|---|---|---|---|
Kim Oishi
CEO | Chief Executive Officer | 62 | 2026-01-26 |
David Kideckel
DFI | Director of Finance/CFO | - | 2025-04-30 |
Mads Daugaard
PSD | President | - | 2020-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 49 | 2025-04-28 | |
David Kideckel
BRD | Director/Board Member | - | 2025-04-28 |
Kim Oishi
BRD | Director/Board Member | 62 | 2026-01-26 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/16/26 | Sell | Director | 500,000 | 2.3643% | ||
| 9/16/26 | Option | Executive/Senior Manager | 300,000 | 1.4186% | ||
| 9/16/26 | Option | Chief Operating Officer | 75,000 | 0.3546% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -16.22% | -6.06% | -18.42% | -81.76% | 4.95M | |
| -2.37% | -5.03% | +39.49% | +62.39% | 62.23B | |
| -2.87% | +0.49% | +11.11% | +69.18% | 54.92B | |
| +0.62% | +2.11% | +16.96% | +102.56% | 55.26B | |
| -3.33% | -5.54% | +19.39% | +35.69% | 42.59B | |
| -2.45% | -2.59% | +16.36% | +98.45% | 41.08B | |
| -1.64% | +2.32% | +219.80% | +789.69% | 40.33B | |
| -5.47% | +24.76% | +101.20% | +87.34% | 33.12B | |
| +0.21% | +1.05% | +14.81% | +46.96% | 32.61B | |
| -2.90% | +17.12% | -42.35% | +337.07% | 23.98B | |
| Average | -3.64% | +6.15% | +37.83% | +154.76% | 38.61B | |
| Weighted average by Cap. | -2.13% | +4.71% | +44.51% | +163.86% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -4.26M -4.77M -3.91M -3.55M -6.66M -452M -6.8M -46.67M -18.81M -238M -17.9M -17.52M -753M | -4.56M -5.1M -4.18M -3.8M -7.13M -483M -7.27M -49.93M -20.13M -255M -19.15M -18.74M -805M |
| Net Debt | 562K 629K 515K 469K 879K 59.55M 896K 6.16M 2.48M 31.43M 2.36M 2.31M 99.28M | 1.53M 1.71M 1.4M 1.28M 2.39M 162M 2.44M 16.75M 6.75M 85.54M 6.42M 6.29M 270M |
Employees
-
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-02 | $0.1550 | -16.22% | 14,046 |
| 26-10-30 | $0.1850 | -2.63% | 1,500 |
| 26-10-29 | $0.1900 | +8.57% | 6,000 |
| 26-10-27 | $0.1750 | +6.06% | 2,500 |
Sell
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
0.1550CAD
Average target price
0.2500CAD
Spread / Average Target
+61.29%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- RKV Stock
Select your edition
All financial news and data tailored to specific country editions
